Biden proposes weight-loss drugs Ozempic, Wegovy be covered by Medicare and Medicaid
Millions of obese Americans would be eligible to receive popular weight-loss drugs like Wigoby and Ozempic covered by Medicare or Medicaid under new rules proposed by the Biden administration Tuesday morning. A costly proposal from the U.S. Department of Health and Human Services is the latest in a potential showdown between the powerful pharmaceutical industry […]
Ozempic, Wegovy and other GLP-1s shown to reduce alcohol-related hospitalizations
Ozempic, Wigovy and other GLP-1 drugs have been shown to counteract the effects of alcohol, a new study suggests. Glucagon-like peptide-1 receptor (GLP-1) agonists (including either semaglutide or liraglutide), which are prescribed to treat type 2 diabetes and obesity, have been reported to reduce alcohol intake when taken. Previous research has shown that. A new […]
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Weight Watchers CEO Sima Sistani abruptly resigned on Friday after a two-year tenure that included controversial adoption of weight-loss drugs such as Ozempic and Wigovy. Sistani pushed the 61-year-old company, known for its in-person meetings and portion control, to buy a telemedicine platform that connects patients with doctors who can prescribe popular obesity drugs. But […]
Sanders, Novo Nordisk CEO clash over Ozempic, Wegovy drug prices
The CEO of Novo Nordisk did not commit to lowering the prices of Ozempic and Wegovi during a Senate hearing on Tuesday, despite repeated pressure from Sen. Bernie Sanders (I-VT), chairman of the Senate Health, Education, Labor and Pensions Committee. Novo Nordisk CEO Lars Fruagaard Jorgensen told senators on Tuesday that pharmacy benefit managers (PBMs), […]
Pfizer moves forward with once-daily weight-loss pill to compete with Wegovy
Pfizer, which discontinued a twice-daily version of the drug late last year, said Thursday that an improved, once-daily version of its weight-loss drug danugliplon will move into clinical trials later this year. The new drug is one of a generation of second-generation weight-loss drugs being developed by companies including Eli Lilly and Novo Nordisk that […]